Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Stephen R Marder, Larry Alphs, Ion-George Anghelescu, Celso Arango, Thomas RE Barnes, Ivo Caers, David G Daniel, Eduardo Dunayevich, W Wolfgang Fleischhacker, George Garibaldi, Michael F Green, Philip D Harvey, Rene S Kahn, John M Kane, Richard SE Keefe, Bruce Kinon, Stefan Leucht, Jean-Pierre Lindenmayer, Anil K Malhotra, Virginia Stauffer Show all
Schizophrenia Research | ELSEVIER SCIENCE BV | Published : 2013
Awarded by Medical Research Council
The meeting was supported by a grant from the NEWMEDS program and Innovative Medicines Initiative Joint Undertaking (IMI JU) by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union.